TrialTransplantation2013

Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients.

A Osama Gaber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.